103 related articles for article (PubMed ID: 30735462)
41. Implementation and evaluation of the human papillomavirus (HPV) vaccination pilot for men who have sex with men (MSM), England, April 2016 to March 2017.
Edelstein M; Iyanger N; Hennessy N; Mesher D; Checchi M; Soldan K; McCall M; Nugent J; Crofts J; Lo J; Gilson R; Powell K; Ramsay M; Yarwood J
Euro Surveill; 2019 Feb; 24(8):. PubMed ID: 30808443
[TBL] [Abstract][Full Text] [Related]
42. Acceptability of two- versus three-dose human papillomavirus vaccination schedule among providers and mothers of adolescent girls: a mixed-methods study in five countries.
Islam JY; Hoyt AM; Ramos S; Morgan K; Kim CJ; de Sanjose S; Butera N; Senkomago V; Richter KL; McDonald MA; Vielot NA; Smith JS
Cancer Causes Control; 2018 Nov; 29(11):1115-1130. PubMed ID: 30284670
[TBL] [Abstract][Full Text] [Related]
43. Associations between parents' satisfaction with provider communication and HPV vaccination behaviors.
Kornides ML; Fontenot HB; McRee AL; Panozzo CA; Gilkey MB
Vaccine; 2018 May; 36(19):2637-2642. PubMed ID: 29627236
[TBL] [Abstract][Full Text] [Related]
44. Recommendations and administration of the HPV vaccine to 11- to 12-year-old girls and boys: a statewide survey of Georgia vaccines for children provider practices.
Luque JS; Tarasenko YN; Dixon BT; Vogel RL; Tedders SH
J Low Genit Tract Dis; 2014 Oct; 18(4):298-303. PubMed ID: 24633170
[TBL] [Abstract][Full Text] [Related]
45. Provider Experience Recommending HPV Vaccination Before Age 11 Years.
Biancarelli DL; Drainoni ML; Perkins RB
J Pediatr; 2020 Feb; 217():92-97. PubMed ID: 31757474
[TBL] [Abstract][Full Text] [Related]
46. Engaging health plans to prioritize HPV vaccination and initiate at age 9.
Foley S; Nkonga J; Fisher-Borne M
Hum Vaccin Immunother; 2023 Dec; 19(1):2167906. PubMed ID: 36722833
[TBL] [Abstract][Full Text] [Related]
47. Measuring Adolescent Human Papillomavirus Vaccine Coverage: A Match of Sexually Transmitted Disease Clinic and Immunization Registry Data.
Pathela P; Jamison K; Papadouka V; Kabir R; Markowitz LE; Dunne EF; Schillinger JA
J Adolesc Health; 2016 Dec; 59(6):710-715. PubMed ID: 27671357
[TBL] [Abstract][Full Text] [Related]
48. Predictors of provider recommendation for HPV vaccine among young adult men and women: findings from a cross-sectional survey.
Gerend MA; Shepherd MA; Lustria ML; Shepherd JE
Sex Transm Infect; 2016 Mar; 92(2):104-7. PubMed ID: 26297720
[TBL] [Abstract][Full Text] [Related]
49. A human rights approach to understanding provider knowledge and attitudes toward the human papillomavirus vaccine in São Paulo, Brazil.
Kruse MH; Bednarczyk RA; Evans DP
Papillomavirus Res; 2020 Jun; 9():100197. PubMed ID: 32275960
[TBL] [Abstract][Full Text] [Related]
50. Human Papillomavirus Vaccine Coverage and Prevalence of Missed Opportunities for Vaccination in an Integrated Healthcare System.
Irving SA; Groom HC; Stokley S; McNeil MM; Gee J; Smith N; Naleway AL
Acad Pediatr; 2018 Mar; 18(2S):S85-S92. PubMed ID: 29502643
[TBL] [Abstract][Full Text] [Related]
51. On surmounting the barriers to HPV vaccination: we can do better.
Attia AC; Wolf J; Núñez AE
Ann Med; 2018 May; 50(3):209-225. PubMed ID: 29316825
[TBL] [Abstract][Full Text] [Related]
52. HPV Vaccination Recommendation Practices among Adolescent Health Care Providers in 5 Countries.
Topazian HM; Kundu D; Peebles K; Ramos S; Morgan K; Kim CJ; Richter KL; Brewer NT; Peris M; Smith JS
J Pediatr Adolesc Gynecol; 2018 Dec; 31(6):575-582.e2. PubMed ID: 30017958
[TBL] [Abstract][Full Text] [Related]
53. Increasing Rates of Human Pipillomavirus Vaccination in Family Practice: A Quality Improvement Project.
Nissen M; Kerkvliet JL; Polkinghorn A; Pugsley L
S D Med; 2019 Aug; 72(8):354-360. PubMed ID: 31465640
[TBL] [Abstract][Full Text] [Related]
54. Sub-Regional Assessment of HPV Vaccination Among Female Adolescents in the Intermountain West and Implications for Intervention Opportunities.
Bodson J; Ding Q; Warner EL; Hawkins AJ; Henry KA; Kepka D
Matern Child Health J; 2017 Jul; 21(7):1500-1511. PubMed ID: 28092058
[TBL] [Abstract][Full Text] [Related]
55. Predictors of Human Papillomavirus Vaccine Follow-Through Among Privately Insured US Patients.
Spencer JC; Brewer NT; Trogdon JG; Wheeler SB; Dusetzina SB
Am J Public Health; 2018 Jul; 108(7):946-950. PubMed ID: 29771616
[TBL] [Abstract][Full Text] [Related]
56. Parents' perceptions of provider communication regarding adolescent vaccines.
Dempsey AF; Pyrzanowski J; Lockhart S; Campagna E; Barnard J; O'Leary ST
Hum Vaccin Immunother; 2016 Jun; 12(6):1469-75. PubMed ID: 27078515
[TBL] [Abstract][Full Text] [Related]
57. Primary care team- and clinic level factors affecting HPV vaccine uptake.
Chuang E; Cabrera C; Mak S; Glenn B; Hochman M; Bastani R
Vaccine; 2017 Aug; 35(35 Pt B):4540-4547. PubMed ID: 28736202
[TBL] [Abstract][Full Text] [Related]
58. Statewide analysis of missed opportunities for human papillomavirus vaccination using vaccine registry data.
Kepka D; Spigarelli MG; Warner EL; Yoneoka Y; McConnell N; Balch A
Papillomavirus Res; 2016 Dec; 2():128-132. PubMed ID: 27540595
[TBL] [Abstract][Full Text] [Related]
59. Achieving high uptake of human papillomavirus vaccine in Cameroon: lessons learned in overcoming challenges.
Ogembo JG; Manga S; Nulah K; Foglabenchi LH; Perlman S; Wamai RG; Welty T; Welty E; Tih P
Vaccine; 2014 Jul; 32(35):4399-4403. PubMed ID: 24968154
[TBL] [Abstract][Full Text] [Related]
60. Human Papillomavirus Vaccination in Washington State: Estimated Coverage and Missed Opportunities, 2006-2013.
Oltean HN; Lofy KH; Goldoft MJ; DeBolt CA
Public Health Rep; 2016; 131(3):474-82. PubMed ID: 27252567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
